期刊文献+

人参皂甙对精神分裂症动物模型大鼠记忆保持的影响 被引量:1

Effect of Ginsenosides on Memory Retention of Rats in Animal Models of Schizophrenia
下载PDF
导出
摘要 目的:探讨人参皂甙(Ginsenosides,GS)对精神分裂症动物模型大鼠记忆保持的影响。方法:入组大鼠随机分为实验组和对照组,实验组给予人参皂甙灌胃,对照组给予生理盐水灌胃,治疗第5天后,两组大鼠同时注射药物MK801(5-甲基二氢二苯并环庚稀亚氨马来酸或地卓西平马来酸盐)建立精神分裂症的动物模型;在用MK801前、第1、3、5天,采用主动回避反应(AAR)和一次性被动回避反应(OPAR)观察各组大鼠的行为变化。结果:给予MK801后,实验组大鼠ARR第1、3、5习得率明显高于对照组(231·79±18·90/158·28±6·78,134·86±15·49/92·29±9·22,81·64±17·29/36·08±17·12,t=10·35、6·68、5·29,P<0·01),且消退也慢于对照组(199·09±15·78/169·44±13·72,128·94±10·80/108·15±13·45,98·06±11·50/42·33±20·08,t=4·01、3·41、6·81,P<0·01)。给MK801后,OPAR训练到第5天,大鼠的步入潜伏期实验组显著大于对照组(79·25±13·49/51·33±11·09,t=4·53,P<0·01),触电次数和触电时间显著低于对照组(4·25±1·49/8·33±2·09,7·25±3·49/27·33±6·09,t=4·49、8·10,P<0·01)。结论:连续口服GS对精神分裂症动物模型大鼠记忆保持能力受损有明显保护作用。在一定的时间内,这种保护作用随动物模型时间的延长面增强。 Objective: To explore the effect of ginsenodels on the memory retention of rats of animal models of schizophrenia. Methods: The rats in experiment were divided into experimental group and control group, the rats in the experimental group were orally given Ginsenosides, and rats in control group were given normal saline. Both groups were treated for 5 days, then given injection of MK801 to establish animal models of schizophrenia. Before (d0) , during (d1, d3) and after (d5) MK801. Several behavior models such as active avoidance reaction (AAR) and once passive avoidance reaction ( OPAR ) were used to research the process of learning and memory before and after experimental. Results: In the active avoidance reaction, the rats of experimental group were used to increase, and the fade away slowed to the rats of controls groups significantly ( 231.79 ± 18. 90/158.28 ± 6. 78, 134. 86 ± 15.49/92. 29 ± 9. 22, 81.64 ± 17. 29/36. 08 ± 17. 12, t = 10. 35, 6. 68, 5. 29, P 〈0. 01 ) . In the once passive avoidance reaction, after establishing the animal models of schizophrenia , through the training of 5 days , the step through latent of the experiment group was longer ( 199.09 ± 15.78/169.44 ± 13.72, 128.94 ± 10.80/108. 15 ± 13.45, 98.06 ± 11.50/42. 33 ± 20. 08, t = 4. 01, 3.41, 6. 81, P 〈 0. 01 ), the number and time of electrified were less than the control group (4. 25 ± 1.49/8. 33 ±2. 09, 7.25 ±3.49/27. 33 ±6. 09, t =4. 49, 8. 10, P 〈0. 01 ) o.Conclusion: Ginsenosides have memory retention facilitating effect on rats in animal models of schizophrenia, the effect may be enhancod by the increase of duration of animal models of schizophrenia.
出处 《中国心理卫生杂志》 CSSCI CSCD 北大核心 2006年第7期437-439,共3页 Chinese Mental Health Journal
关键词 人参皂甙 记忆保持 动物研究 精神分裂症动物模型 大鼠 MK801 schizophrenia animal models MK801 memory retention Ginsenosides
  • 相关文献

参考文献9

二级参考文献14

  • 1Warner R, Girolamo D. Schizophrenia. Geneva: World Health Organization, 1995.
  • 2Diagnostic and Statistical and Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association, 1987.
  • 3Alan AB, Glen BB, Mathew TM. Animal Models in Psychiatry I. Clifton: Humana Press. 1991.
  • 4Amy RM, Raul BG, Marc GC, Beverly HK. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999; 98:427 - 436.
  • 5Carlsson M, Carlsson A. Interactions between glutamateric and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease. Trends Neurosci 1990;13:272-276.
  • 6Carlsson A, Hansson LO, Waters N, Carlsson ML. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. Life Sci 1997;61:75 --94.
  • 7Ban TA, Guy W, Wilson WH. Description and distribution of the subtypes of chronic schizophrenia based on Leonhard's classification. Psychiatr Dev 1984 ;2(3) :179- 199.
  • 8Guan HG, Dai JZ, Xing Z. Atypical antipsychotic effects of Quetiapine fumarate in animal models . Acta Pharmacol Sin 2000;21:205 -210.
  • 9Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 1970; 11 :303 -404.
  • 10Griffith JD, Cavanaugh J, Held J. Oates JA. Dextroampetamine: evaluation of psychotomimetic properties in man. Arch Gen Psychiatry 1972 ;26:97 - 100.

共引文献41

同被引文献7

  • 1Kato TA,Monji A, Mizoguchi Y Inflammatory properties of antipsychotics modulations:are antipsychotics a'fire et al. Anti- via microglia extinguisher' in the brain of schizophrenia?[J] Mini Rev Med Chem 2011, 11(7): 565-74.
  • 2Perala J, Suvisaari l, Saarni SI,Kuoppasalmi K, Isometsa E, et al. (2007) Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry, 2007,64:19-28.
  • 3Braff DL, Swerdlow NR, Geyer MA. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry, 1999,156(4):596-602.
  • 4Kumari V, Soni Mathew VM, Sharma V. Prepulse inhibition of the startle response in men with schizophrenia:effects of age of onset of illness, symptoms, and medication. Arch Gen Psychiatry, 2000,57(6):609-14.
  • 5Lim AL, Taylor DA, Malone DT. Consequences of early life MK-801 administration:long-term behavioural effects and relevance to schizophrenia research. Behav Brain Res, 2012, 227(1):276-86.
  • 6于文娟,朱浩,卢卫红,金志兴,朱丽萍.MK-801建立谷氨酸功能低下精神分裂症大鼠模型的研究[J].中国神经精神疾病杂志,2011,37(10):621-624. 被引量:9
  • 7罗霞,张文蔚,蒋廷云,刘磊,薛丽,吴业达,赵存友,赵虎.汉族成年精神分裂症患者的性别和症状亚型差异[J].中华脑科疾病与康复杂志(电子版),2013,3(4):16-22. 被引量:5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部